2.50
                                            Schlusskurs vom Vortag:
              $2.35
            Offen:
              $2.35
            24-Stunden-Volumen:
                2.25M
            Relative Volume:
              1.44
            Marktkapitalisierung:
                $132.86M
            Einnahmen:
              $832.00K
            Nettoeinkommen (Verlust:
              $-135.12M
            KGV:
              -0.4105
            EPS:
                -6.09
            Netto-Cashflow:
                $-124.69M
            1W Leistung:
              +0.40%
            1M Leistung:
              +2.88%
            6M Leistung:
                +30.21%
            1J Leistung:
              -54.13%
            Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Firmenname
                  
                      Inovio Pharmaceuticals Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (858) 410-3134
                    
                Adresse
                  
                      660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
                    
                Vergleichen Sie INO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                INO
                            
                             
                        Inovio Pharmaceuticals Inc 
                           | 
                    2.50 | 124.89M | 832.00K | -135.12M | -124.69M | -6.09 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight | 
| 2024-05-14 | Eingeleitet | Stephens | Overweight | 
| 2024-01-25 | Hochstufung | Oppenheimer | Perform → Outperform | 
| 2022-11-09 | Herabstufung | Maxim Group | Buy → Hold | 
| 2022-11-01 | Herabstufung | BofA Securities | Neutral → Underperform | 
| 2022-07-19 | Fortgesetzt | RBC Capital Mkts | Sector Perform | 
| 2022-05-11 | Herabstufung | Oppenheimer | Outperform → Perform | 
| 2022-01-21 | Hochstufung | BofA Securities | Underperform → Neutral | 
| 2021-12-29 | Fortgesetzt | Jefferies | Hold | 
| 2021-09-10 | Herabstufung | BofA Securities | Neutral → Underperform | 
| 2021-06-24 | Eingeleitet | Jefferies | Hold | 
| 2021-03-23 | Eingeleitet | BofA Securities | Neutral | 
| 2021-02-12 | Eingeleitet | Oppenheimer | Outperform | 
| 2020-11-17 | Herabstufung | ROTH Capital | Neutral → Sell | 
| 2020-11-10 | Hochstufung | ROTH Capital | Sell → Neutral | 
| 2020-09-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral | 
| 2020-09-28 | Hochstufung | Maxim Group | Hold → Buy | 
| 2020-07-01 | Herabstufung | Maxim Group | Buy → Hold | 
| 2020-07-01 | Herabstufung | ROTH Capital | Neutral → Sell | 
| 2020-06-29 | Herabstufung | H.C. Wainwright | Buy → Neutral | 
| 2020-06-26 | Herabstufung | Stifel | Buy → Hold | 
| 2020-05-21 | Eingeleitet | The Benchmark Company | Buy | 
| 2020-04-30 | Herabstufung | ROTH Capital | Buy → Neutral | 
| 2020-03-13 | Herabstufung | Piper Sandler | Overweight → Neutral | 
| 2020-03-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform | 
| 2019-12-19 | Eingeleitet | ROTH Capital | Buy | 
| 2018-02-15 | Bestätigt | Maxim Group | Buy | 
| 2017-10-18 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2017-09-06 | Eingeleitet | Citigroup | Buy | 
| 2017-06-08 | Hochstufung | Piper Jaffray | Neutral → Overweight | 
| 2017-05-24 | Bestätigt | Maxim Group | Buy | 
| 2017-03-16 | Hochstufung | Maxim Group | Hold → Buy | 
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral | 
                    Alle ansehen
                    
                  
                Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
INOVIO to Present at Stephens Virtual Biotechnology Conference on November 4 - MyChesCo
How to read the order book for Inovio Pharmaceuticals Inc.Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
What RSI levels show for Inovio Pharmaceuticals Inc. (GBM) stockMarket Rally & Weekly Stock Performance Updates - newser.com
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe chartsWeekly Risk Report & Daily Chart Pattern Signals - newser.com
Why Inovio Pharmaceuticals Inc. stock is a value investor pickAnalyst Downgrade & Safe Swing Trade Setup Alerts - newser.com
Is Inovio Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Can Inovio Pharmaceuticals Inc. stock outperform in 2025 bull market2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock expand revenue streams2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Inovio (INO) Finalizes BLA Submission for INO-3107 - GuruFocus
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfoliosLong Setup & AI Enhanced Trade Execution Alerts - newser.com
Statistical indicators supporting Inovio Pharmaceuticals Inc.’s strengthShare Buyback & Growth Focused Stock Reports - newser.com
Strategies to average down on Inovio Pharmaceuticals Inc.Bull Run & Technical Entry and Exit Alerts - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsExit Point & Momentum Based Trading Ideas - newser.com
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - PR Newswire
Will Inovio Pharmaceuticals Inc. stock go up soonJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Why hedge funds are buying Inovio Pharmaceuticals Inc. stock2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
How to use a screener to detect Inovio Pharmaceuticals Inc. breakoutsTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com
Is Inovio Pharmaceuticals Inc. stock attractive after correctionRecession Risk & Weekly High Return Forecasts - newser.com
Will breakout in Inovio Pharmaceuticals Inc. lead to full recovery2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Published on: 2025-11-03 04:28:05 - newser.com
Price momentum metrics for Inovio Pharmaceuticals Inc. explainedBull Run & Capital Efficient Trading Techniques - newser.com
Will Inovio Pharmaceuticals Inc. stock rally after Fed decisionsQuarterly Trade Summary & Verified Entry Point Signals - newser.com
What momentum indicators show for Inovio Pharmaceuticals Inc. stock2025 Key Lessons & Safe Capital Allocation Plans - newser.com
Chart based analysis of Inovio Pharmaceuticals Inc. trendsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
How risky is Inovio Pharmaceuticals Inc. stock nowJuly 2025 Action & Stepwise Trade Signal Implementation - newser.com
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthGap Up & Weekly High Conviction Ideas - newser.com
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stock2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock reach $200 price targetGold Moves & AI Forecast Swing Trade Picks - newser.com
Published on: 2025-11-02 13:43:13 - newser.com
Published on: 2025-11-02 06:09:53 - newser.com
Why Inovio Pharmaceuticals Inc. stock appeals to dividend seekers2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Inovio Pharmaceuticals Q3 Earnings Tops Estimates, Lifts Retail Sentiment - MSN
Inovio Pharmaceuticals, Inc. (INO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Published on: 2025-11-01 12:25:46 - newser.com
INOVIO’s DNA-Encoded Antibody Trial Shows Durable In Vivo Expression - MyChesCo
Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):